Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Prediction Tool Effective for Assessing cSCC Risk

J Invest Dermatol; ePub 2018 Jul 2; Wang, et al

cSCCscore, a prediction tool that uses patients’ covariates and clinical histories to assign them personal probabilities of developing cutaneuous squamous cell cancers (cSCCs) within 3 years following risk assessment, can facilitate more informed management of non-Hispanic white (NHW) patients at cSCC risk. This according to a recent study that examined cSCCscore using cohort data from 66,995 patients in the Kaiser Permanente Northern California healthcare system. Researchers found:

  • Patients’ covariates and histories explained about 75% of their interpersonal cSCC risk variation.
  • Using cross-validated performance measures, cSCCscore’s predictions were moderately well calibrated to the patients’ observed cSCC incidence.
  • Moreover, cSCCscore discriminated well between patients who subsequently did and did not develop a new primary cSCC within 3 years following risk assignment, with area under the receiver operating characteristic curve (AUC) of approximately 85%.

Citation:

Wang W, Jorgenson E, Joannidis NM, Asgari MM, Whittemore AS. A prediction tool to facilitate risk-stratified screening for squamous cell skin cancer. [Published online ahead of print July 2, 2018]. J Invest Dermatol. doi:10.1016/j.jid.2018.03.1528.

This Week's Must Reads

ALT-70 Gets High Marks for Diagnosing Cellulitis, J Am Acad Dermatol; ePub 2018 Jul 9; Li, et al

MMS/MART-1 Immunostaining for Atypical Melanocytes, J Am Acad Dermatol; ePub 2018 Jul 9; Etzkorn, et al

Economic Analysis of Noninvasive Pathologic Assay, JAMA Dermatology; ePub 2018 Jul 11; Hornberger, et al

Use of Advanced Practice Professionals on the Rise, JAMA Dermatology; ePub 2018 Jul 11; Zhang, et al

Folate and Risk of Cutaneous Melanoma in Women, Cancer Epidemiol; 2018 Aug; Dhana, Ten, Li, et al

Must Reads in Nonmelanoma Skin Cancer

Prediction Tool Effective for Assessing cSCC Risk, J Invest Dermatol; ePub 2018 Jul 2; Wang, et al

Primary Closure Lengths in MMS Based on Cancer Type, Dermatolog Surg; ePub 2018 Jun 8; Theroux, et al

Risk Factors for BCC in Men Younger Than 40 Years, Dermatolog Surg; ePub 2018 May 9; Nemer, et al

Mohs Surgery Referral for Patients <50 with NMSC, J Drugs Dermatol; 2018 May; Quatrano, Mu, et al

Facial BCC in Patients Younger Than 40 Years, J Drugs Dermatol; 2018 May; Nadimi, et al